doxazosin mesylatedrugHigh PriorityActive

Doxazosin Recall

Doxazosin Tablets has been recalled due to tablets/capsules imprinted with wrong id. Consumers who purchased this product should stop using it immediately. Check the official FDA notice for specific lot numbers and return or disposal instructions.

By RecallRadar Editorial Team

Sourced from FDA. Last verified March 4, 2026.

On this page

Free checker

Check if you qualify

See whether your device may qualify for a free repair or replacement program before you spend money.

Check if you qualify

Key facts

Date announced: January 21, 2026
Source agency: FDA

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

What's Being Recalled

Quoted source excerpt from the official notice.

Tablets/Capsules Imprinted with Wrong ID

Quick Info

Key facts from the official notice, kept in the article flow for easy cross-checking.

Brand: Doxazosin mesylate
Category: drug
Source agency: FDA
Announced: January 21, 2026
Country: US
Status: Active

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot # GDSH25006, Exp Date: 08/2027

#	Model
1	Lot # GDSH25006, Exp Date: 08/2027

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

What You Should Do

Follow the remedy path from the official notice using the exact model and serial details above.

1## Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pil Agency: FDA | Category: drug Reason: Tablets/Capsules Imprinted with Wrong ID What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice Get Alerts for doxazosin mesylate Devices

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: January 21, 2026
Last reviewed by RecallRadar: March 4, 2026

Frequently Asked Questions

Am I affected by this recall?

Check the affected models section on this page. The official notice currently lists Lot # GDSH25006, Exp Date: 08/2027.

What is the remedy for this recall?

## Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceuticals (USA), Inc., 1 Tower Center Boulevard, Suite 2200, East Brunswick, NJ 08816 USA, manufactured by Unichem Laboratories Limited, Plot Number 15 to 18, Pil Agency: FDA | Category: drug Reason: Tablets/Capsules Imprinted with Wrong ID What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: doxazosin mesylate recall hub and Food & Drug recall hub.